AbbVie Analysts Lead the Stock Higher as Humira Worries Recede
MarketBeatAbbVie had a solid quarter, accelerating growth and giving positive guidance that has analysts lifting their price targets and the stock advancing.
AbbVie had a solid quarter, accelerating growth and giving positive guidance that has analysts lifting their price targets and the stock advancing.